Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fibrotic Diseases of the Retroperitoneum & Skin, & Rare Scleroderma Mimics

Susan Bernstein  |  Issue: January 2018  |  January 19, 2018

In scleromyxedema, a patient’s hands may be hard to distinguish from those of someone with diffuse systemic sclerosis, but skin may have a papular quality that when touched feels like cobblestones, said Dr. Hummers. Scleromyxedema is systemic, rare, almost always found in adults, associated with monoclonal gammopathy of undetermined significance (MGUS), and its skin/neurological form is life threatening. Patients frequently have papules on the mid-back, and/or around the glabella, forehead and ears. Papules may coalesce, and skin texture is thickened.

“One of the clinical pearls in differentiating scleromyxedema from scleroderma is this very characteristic, distinct involvement of the ear, where you can see papules behind the ear.7 Even if you can’t see them, you will feel these papules,” said Dr. Hummers. Patients may also have distinct papules on their hands, sclerodactyly, and indentation of the skin on the knuckles called the “donut sign.” Patients may have elephantine thickening of the skin around their knees called pachydermia. Scleromyxedema can rarely progress to multiple myeloma or even smoldering myeloma, said Dr. Hummers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Scleromyxedema may have scleroderma-like features, such as dysphagia and, less often, Raynaud’s phenomenon. Patients should have normal nailfold capillaroscopy and may have inflammatory polyarthritis in small hand joints. Patients with the life-threatening dermato-neuro syndrome present with encephalo­pathic symptoms that are non-specific, and may begin as confusion. They may rapidly progress to seizures and coma. Patients whose skin disease is well controlled very rarely have this manifestation, she said.

Diagnosis is made with physical exam, MGUS protein on blood screening panels and a skin biopsy. Look for mucin deposition that is apparent only with special staining, and separation between collagen bundles and increased spindled fibroblasts, she said. Scleromyxedema patients nearly all respond well to intravenous immunoglobulin, but maintenance therapy is required every six to 12 weeks for life, she said. Lenalidomide or thalidomide may be used to treat the underlying MGUS, but can have side effects that affect quality of life.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Scleredema is another very rare scleroderma mimic that is either post-infectious, associated with MGUS, or associated with poorly controlled type 2 diabetes, said Dr. Hummers.8 Skin tightening may become painful or restrictive. Patients present with a slowly progressive, doughy, non-pitting edema that typically begins around the upper back and neck, and then progresses to the upper arms, lower arms, chest, face and legs. Unlike scleroderma, it spares the fingers and feet.

Skin biopsy with special staining shows separation between collagen bundles and mucin deposition. Treat the underlying infection, MGUS or diabetes associated with scleredema. UVA-1 phototherapy may be effective for treating severe skin disease.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsSystemic Sclerosis Tagged with:ACR/ARHP Annual Meetingeosinophilic fasciitisfibrosisIgG4 related diseaseScleroderma

Related Articles
    IgG4-Related Kidney Disease: Diagnostics, Manifestations, & More

    IgG4-Related Kidney Disease: Diagnostics, Manifestations & More

    May 17, 2018

    Immunoglobin G4-related disease (IgG4-RD) is a rare fibro-inflammatory disease of unknown etiology that has been recently recognized. It can cause fibro-inflammatory masses in almost every organ of the body and is associated with dense lymphoplasmacytic infiltration of IgG4-postitive plasma cells, storiform fibrosis and elevated levels of serum IgG4.1 IgG4-RD is a systemic disease that may…

    A Spotlight on IgG4-Related Disease

    January 1, 2013

    What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

    Case Report: Atypical Presentation of Idiopathic Retroperitoneal Fibrosis

    March 14, 2022

    Retroperitoneal fibrosis (RPF) is a rare condition characterized by aberrant fibroinflammatory tissue developing in the retroperitoneum. This disorder was initially called Ormond’s disease. RPF may be idiopathic or secondary to other conditions. Idiopathic RPF is a part of the disease spectrum of chronic periaortitis due to its typical periaortoiliac localization. Idiopathic retroperitoneal fibrosis is a…

    Research Sheds Light on Scleromyxedema, a Rare Skin Disorder

    October 18, 2019

    Scleromyxedema is a rare, mucinous skin disorder of unknown origin, one of a number of conditions that mimic systemic sclerosis. Although cases of scleromyxedema remain rare, a better understanding of its mechanisms of action could have implications for the research and treatment of scleroderma and related autoimmune conditions, says Laura K. Hummers, MD, ScM, co-director…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences